AgreementGroup Agreement • September 3rd, 2024 • Deutsch Todd • Biological products, (no disgnostic substances)
THIS AGREEMENT (the “Agreement”), dated as of September 3, 2024 (the “Effective Date”), is by and among Ted D. Kellner (the “Nominating Stockholder”), as nominating stockholder and a nominee, and Todd Deutsch and Robert L. Chioini (the “Other Nominees”), as additional nominees (each, a “Party” and, collectively, the “Parties”).
Group AgreementGroup Agreement • July 27th, 2023 • Deutsch Todd • Biological products, (no disgnostic substances)
THIS AGREEMENT (the “Agreement”), dated as of July 26, 2023 (the “Effective Date”), is by and among Robert L. Chioini (“Chioini”), Todd Deutsch (“Deutsch”) and Ted D. Kellner (“Kellner”) (each, a “Party” and, collectively, the “Parties”).
Amendment to Group AgreementGroup Agreement • January 3rd, 2024 • Deutsch Todd • Biological products, (no disgnostic substances)
THIS AMENDMENT, dated as of January 3, 2024 (the “Amendment”), to that certain AGREEMENT (the “Agreement”), dated as of July 26, 2023 (the “Effective Date”), is by and among Robert L. Chioini (“Chioini”), Todd Deutsch (“Deutsch”) and Ted D. Kellner (“Kellner”) (each, a “Party” and, collectively, the “Parties”). Capitalized terms used but not defined in this Amendment shall have the meanings ascribed to such terms in the Agreement.
JOINDER AGREEMENTJoinder Agreement • December 17th, 2024 • Deutsch Todd • Biological products, (no disgnostic substances)
This JOINDER AGREEMENT (the “Joinder”) is dated as of December 14, 2024 by and among Ted D. Kellner (the “Nominating Stockholder”), as nominating stockholder and a nominee, and Todd Deutsch, Robert L. Chioini and Paul Sweeney (the “Other Nominees,” and together with the Nominating Stockholder, the “Nominees”), and William A. Carter and Wayne Springate (the “Cooperating Parties”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 27th, 2023 • Deutsch Todd • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of the Common Stock of the Company and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 27th day of July, 2023.
JOINT FILING AGREEMENTJoint Filing Agreement • December 17th, 2024 • Deutsch Todd • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the shares of the Common Stock of the Company and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 12th day of December, 2024.
